Serveur d'exploration sur l'opéra

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Effect of Paricalcitol on Left Ventricular Mass and Function in CKD-The OPERA Trial

Identifieur interne : 000450 ( Main/Exploration ); précédent : 000449; suivant : 000451

Effect of Paricalcitol on Left Ventricular Mass and Function in CKD-The OPERA Trial

Auteurs : Angela Yee-Moon Wang [Hong Kong] ; FANG FANG [Hong Kong] ; John Chan [Hong Kong] ; Yue-Yi Wen [Hong Kong] ; SHANG QING [Hong Kong] ; Iris Hiu-Shuen Chan [Hong Kong] ; Gladys Lo [Hong Kong] ; Kar-Neng Lai [Hong Kong] ; Wai-Kei Lo [Hong Kong] ; Christopher Wai-Kei Lam [République populaire de Chine] ; Cheuk-Man Yu [Hong Kong]

Source :

RBID : Pascal:14-0078136

Descripteurs français

English descriptors

Abstract

Vitamin D seems to protect against cardiovascular disease, but the reported effects of vitamin D on patient outcomes in CKD are controversial. We conducted a prospective, double blind, randomized, placebo-controlled trial to determine whether oral activated vitamin D reduces left ventricular (LV) mass in patients with stages 3-5 CKD with LV hypertrophy. Subjects with echocardiographic criteria of LV hypertrophy were randomly assigned to receive either oral paricalcitol (1 μg) one time daily (n=30) or matching placebo (n=30) for 52 weeks. The primary end point was change in LV mass index over 52 weeks, which was measured by cardiac magnetic resonance imaging. Secondary end points included changes in LV volume, echocardiographic measures of systolic and diastolic function, biochemical parameters of mineral bone disease, and measures of renal function. Change in LV mass index did not differ significantly between groups (median [interquartile range], -2.59 [-6.13 to 0.32] g/m2 with paricalcitol versus -4.85 [-9.89 to 1.10] g/m2 with placebo). Changes in LV volume, ejection fraction, tissue Doppler-derived measures of early diastolic and systolic mitral annular velocities, and ratio of early mitral inflow velocity to early diastolic mitral annular velocity did not differ between the groups. However, paricalcitol treatment significantly reduced intact parathyroid hormone (P<0.001) and alkaline phosphatase (P=0.001) levels as well as the number of cardiovascular-related hospitalizations compared with placebo. In conclusion, 52 weeks of treatment with oral paricalcitol (1 μg one time daily) significantly improved secondary hyperparathyroidism but did not alter measures of LV structure and function in patients with severe CKD.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Effect of Paricalcitol on Left Ventricular Mass and Function in CKD-The OPERA Trial</title>
<author>
<name sortKey="Wang, Angela Yee Moon" sort="Wang, Angela Yee Moon" uniqKey="Wang A" first="Angela Yee-Moon" last="Wang">Angela Yee-Moon Wang</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Medicine, Queen Mary Hospital, University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<wicri:noRegion>Department of Medicine, Queen Mary Hospital, University of Hong Kong</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fang Fang" sort="Fang Fang" uniqKey="Fang Fang" last="Fang Fang">FANG FANG</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<placeName>
<settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
<author>
<name sortKey="Chan, John" sort="Chan, John" uniqKey="Chan J" first="John" last="Chan">John Chan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Department of Diagnostic Radiology, Hong Kong Sanatorium Hospital</s1>
<s3>HKG</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<wicri:noRegion>Department of Diagnostic Radiology, Hong Kong Sanatorium Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wen, Yue Yi" sort="Wen, Yue Yi" uniqKey="Wen Y" first="Yue-Yi" last="Wen">Yue-Yi Wen</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<placeName>
<settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
<author>
<name sortKey="Shang Qing" sort="Shang Qing" uniqKey="Shang Qing" last="Shang Qing">SHANG QING</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<placeName>
<settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
<author>
<name sortKey="Chan, Iris Hiu Shuen" sort="Chan, Iris Hiu Shuen" uniqKey="Chan I" first="Iris Hiu-Shuen" last="Chan">Iris Hiu-Shuen Chan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Department of Pathology, United Christian Hospital</s1>
<s3>HKG</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<wicri:noRegion>Department of Pathology, United Christian Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lo, Gladys" sort="Lo, Gladys" uniqKey="Lo G" first="Gladys" last="Lo">Gladys Lo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Department of Diagnostic Radiology, Hong Kong Sanatorium Hospital</s1>
<s3>HKG</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<wicri:noRegion>Department of Diagnostic Radiology, Hong Kong Sanatorium Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lai, Kar Neng" sort="Lai, Kar Neng" uniqKey="Lai K" first="Kar-Neng" last="Lai">Kar-Neng Lai</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Medicine, Queen Mary Hospital, University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<wicri:noRegion>Department of Medicine, Queen Mary Hospital, University of Hong Kong</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lo, Wai Kei" sort="Lo, Wai Kei" uniqKey="Lo W" first="Wai-Kei" last="Lo">Wai-Kei Lo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Department of Medicine, Tung Wah Hospital</s1>
<s3>HKG</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<wicri:noRegion>Department of Medicine, Tung Wah Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lam, Christopher Wai Kei" sort="Lam, Christopher Wai Kei" uniqKey="Lam C" first="Christopher Wai-Kei" last="Lam">Christopher Wai-Kei Lam</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology</s1>
<s2>Macau</s2>
<s3>CHN</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<wicri:noRegion>Macau</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yu, Cheuk Man" sort="Yu, Cheuk Man" uniqKey="Yu C" first="Cheuk-Man" last="Yu">Cheuk-Man Yu</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<placeName>
<settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">14-0078136</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0078136 INIST</idno>
<idno type="RBID">Pascal:14-0078136</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000014</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000514</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000010</idno>
<idno type="wicri:doubleKey">1046-6673:2014:Wang A:effect:of:paricalcitol</idno>
<idno type="wicri:Area/Main/Merge">000439</idno>
<idno type="wicri:Area/Main/Curation">000450</idno>
<idno type="wicri:Area/Main/Exploration">000450</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Effect of Paricalcitol on Left Ventricular Mass and Function in CKD-The OPERA Trial</title>
<author>
<name sortKey="Wang, Angela Yee Moon" sort="Wang, Angela Yee Moon" uniqKey="Wang A" first="Angela Yee-Moon" last="Wang">Angela Yee-Moon Wang</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Medicine, Queen Mary Hospital, University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<wicri:noRegion>Department of Medicine, Queen Mary Hospital, University of Hong Kong</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fang Fang" sort="Fang Fang" uniqKey="Fang Fang" last="Fang Fang">FANG FANG</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<placeName>
<settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
<author>
<name sortKey="Chan, John" sort="Chan, John" uniqKey="Chan J" first="John" last="Chan">John Chan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Department of Diagnostic Radiology, Hong Kong Sanatorium Hospital</s1>
<s3>HKG</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<wicri:noRegion>Department of Diagnostic Radiology, Hong Kong Sanatorium Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wen, Yue Yi" sort="Wen, Yue Yi" uniqKey="Wen Y" first="Yue-Yi" last="Wen">Yue-Yi Wen</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<placeName>
<settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
<author>
<name sortKey="Shang Qing" sort="Shang Qing" uniqKey="Shang Qing" last="Shang Qing">SHANG QING</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<placeName>
<settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
<author>
<name sortKey="Chan, Iris Hiu Shuen" sort="Chan, Iris Hiu Shuen" uniqKey="Chan I" first="Iris Hiu-Shuen" last="Chan">Iris Hiu-Shuen Chan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Department of Pathology, United Christian Hospital</s1>
<s3>HKG</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<wicri:noRegion>Department of Pathology, United Christian Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lo, Gladys" sort="Lo, Gladys" uniqKey="Lo G" first="Gladys" last="Lo">Gladys Lo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Department of Diagnostic Radiology, Hong Kong Sanatorium Hospital</s1>
<s3>HKG</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<wicri:noRegion>Department of Diagnostic Radiology, Hong Kong Sanatorium Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lai, Kar Neng" sort="Lai, Kar Neng" uniqKey="Lai K" first="Kar-Neng" last="Lai">Kar-Neng Lai</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Medicine, Queen Mary Hospital, University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<wicri:noRegion>Department of Medicine, Queen Mary Hospital, University of Hong Kong</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lo, Wai Kei" sort="Lo, Wai Kei" uniqKey="Lo W" first="Wai-Kei" last="Lo">Wai-Kei Lo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Department of Medicine, Tung Wah Hospital</s1>
<s3>HKG</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<wicri:noRegion>Department of Medicine, Tung Wah Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lam, Christopher Wai Kei" sort="Lam, Christopher Wai Kei" uniqKey="Lam C" first="Christopher Wai-Kei" last="Lam">Christopher Wai-Kei Lam</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology</s1>
<s2>Macau</s2>
<s3>CHN</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<wicri:noRegion>Macau</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yu, Cheuk Man" sort="Yu, Cheuk Man" uniqKey="Yu C" first="Cheuk-Man" last="Yu">Cheuk-Man Yu</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<placeName>
<settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of the American Society of Nephrology</title>
<title level="j" type="abbreviated">J. Am. Soc. Nephrol.</title>
<idno type="ISSN">1046-6673</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of the American Society of Nephrology</title>
<title level="j" type="abbreviated">J. Am. Soc. Nephrol.</title>
<idno type="ISSN">1046-6673</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Chronic kidney disease</term>
<term>Clinical trial</term>
<term>Left ventricle performance</term>
<term>Mass</term>
<term>Nephrology</term>
<term>Paricalcitol</term>
<term>Urology</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Paricalcitol</term>
<term>Fonction ventriculaire gauche</term>
<term>Masse</term>
<term>Néphropathie chronique</term>
<term>Essai clinique</term>
<term>Néphrologie</term>
<term>Urologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Vitamin D seems to protect against cardiovascular disease, but the reported effects of vitamin D on patient outcomes in CKD are controversial. We conducted a prospective, double blind, randomized, placebo-controlled trial to determine whether oral activated vitamin D reduces left ventricular (LV) mass in patients with stages 3-5 CKD with LV hypertrophy. Subjects with echocardiographic criteria of LV hypertrophy were randomly assigned to receive either oral paricalcitol (1 μg) one time daily (n=30) or matching placebo (n=30) for 52 weeks. The primary end point was change in LV mass index over 52 weeks, which was measured by cardiac magnetic resonance imaging. Secondary end points included changes in LV volume, echocardiographic measures of systolic and diastolic function, biochemical parameters of mineral bone disease, and measures of renal function. Change in LV mass index did not differ significantly between groups (median [interquartile range], -2.59 [-6.13 to 0.32] g/m
<sup>2 </sup>
with paricalcitol versus -4.85 [-9.89 to 1.10] g/m
<sup>2</sup>
with placebo). Changes in LV volume, ejection fraction, tissue Doppler-derived measures of early diastolic and systolic mitral annular velocities, and ratio of early mitral inflow velocity to early diastolic mitral annular velocity did not differ between the groups. However, paricalcitol treatment significantly reduced intact parathyroid hormone (P<0.001) and alkaline phosphatase (P=0.001) levels as well as the number of cardiovascular-related hospitalizations compared with placebo. In conclusion, 52 weeks of treatment with oral paricalcitol (1 μg one time daily) significantly improved secondary hyperparathyroidism but did not alter measures of LV structure and function in patients with severe CKD.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Hong Kong</li>
<li>République populaire de Chine</li>
</country>
<settlement>
<li>Sha Tin</li>
</settlement>
<orgName>
<li>Université chinoise de Hong Kong</li>
</orgName>
</list>
<tree>
<country name="Hong Kong">
<noRegion>
<name sortKey="Wang, Angela Yee Moon" sort="Wang, Angela Yee Moon" uniqKey="Wang A" first="Angela Yee-Moon" last="Wang">Angela Yee-Moon Wang</name>
</noRegion>
<name sortKey="Chan, Iris Hiu Shuen" sort="Chan, Iris Hiu Shuen" uniqKey="Chan I" first="Iris Hiu-Shuen" last="Chan">Iris Hiu-Shuen Chan</name>
<name sortKey="Chan, John" sort="Chan, John" uniqKey="Chan J" first="John" last="Chan">John Chan</name>
<name sortKey="Fang Fang" sort="Fang Fang" uniqKey="Fang Fang" last="Fang Fang">FANG FANG</name>
<name sortKey="Lai, Kar Neng" sort="Lai, Kar Neng" uniqKey="Lai K" first="Kar-Neng" last="Lai">Kar-Neng Lai</name>
<name sortKey="Lo, Gladys" sort="Lo, Gladys" uniqKey="Lo G" first="Gladys" last="Lo">Gladys Lo</name>
<name sortKey="Lo, Wai Kei" sort="Lo, Wai Kei" uniqKey="Lo W" first="Wai-Kei" last="Lo">Wai-Kei Lo</name>
<name sortKey="Shang Qing" sort="Shang Qing" uniqKey="Shang Qing" last="Shang Qing">SHANG QING</name>
<name sortKey="Wen, Yue Yi" sort="Wen, Yue Yi" uniqKey="Wen Y" first="Yue-Yi" last="Wen">Yue-Yi Wen</name>
<name sortKey="Yu, Cheuk Man" sort="Yu, Cheuk Man" uniqKey="Yu C" first="Cheuk-Man" last="Yu">Cheuk-Man Yu</name>
</country>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Lam, Christopher Wai Kei" sort="Lam, Christopher Wai Kei" uniqKey="Lam C" first="Christopher Wai-Kei" last="Lam">Christopher Wai-Kei Lam</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000450 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000450 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Musique
   |area=    OperaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:14-0078136
   |texte=   Effect of Paricalcitol on Left Ventricular Mass and Function in CKD-The OPERA Trial
}}

Wicri

This area was generated with Dilib version V0.6.21.
Data generation: Thu Apr 14 14:59:05 2016. Site generation: Thu Oct 8 06:48:41 2020